Categories AlphaGraphs, Earnings, Technology

Infographic: Highlights of Snap’s Q1 2022 earnings report

Multimedia messaging platform Snap, Inc. (NYSE: SNAP) reported a net loss for the first quarter of 2022 when the company’s revenues grew in double digits but fell short of Wall Street’s expectations.

Snap Q1 2022 earnings infographic

First-quarter net loss, on an adjusted basis, was $0.02 per share, compared to breakeven in the same period of 2021. Analysts had predicted profit for the most recent quarter.

On an unadjusted basis, the company reported a net loss of $359.6 million or $0.22 per share, compared to a loss of $286.9 million or $0.19 per share in the first quarter of last year. Meanwhile, revenues increased 38% annually to $1.06 billion, which slightly missed analysts’ forecast.


Check this space to read management/analysts’ comments on Snap’s Q1 2022 earnings


“We remain focused on providing value for our growing community, delivering ROI for our advertising partners, and investing against our enormous opportunity in augmented reality. We’re excited to share many new products and services at our annual Snap Partner Summit next week,” said Evan Spiegel, CEO of Snap.

Prior Performance

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top